{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:03:26Z","timestamp":1790957006987,"version":"4.1.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["T32 MH015442"],"award-info":[{"award-number":["T32 MH015442"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>\n                    This study aimed to characterize pregnant individuals\u2019 use of cannabidiol (CBD). Data are from the International Cannabis Policy Study (2019\u20132021), a repeated cross-sectional survey of individuals aged 16\u201365 years in the United States and Canada (N=66,457 women, including 1,096 pregnant women). The primary analysis compared pregnant and nonpregnant women's CBD-only product use patterns and reasons for use. The prevalence of CBD-only use in pregnant women was 20.4% compared with 11.3% among nonpregnant women,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;.001. Reasons for CBD use among pregnant women included anxiety (58.4%), depression (40.3%), posttraumatic stress disorder (32.1%); pain (52.3%), headache (35.6%), and nausea or vomiting (31.9%). Thus, CBD-only product use was prevalent in this large sample, with one in five pregnant women reporting use. Characterization of prenatal CBD use is an important first step to exploring potential risks to exposed offspring.\n                  <\/jats:p>","DOI":"10.1097\/aog.0000000000005603","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T17:00:55Z","timestamp":1715274055000},"page":"156-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Cannabidiol-Only Product Use in Pregnancy in the United States and Canada"],"prefix":"10.1097","volume":"144","author":[{"given":"Devika","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharonya","family":"Battula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mikulich-Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"e2145653","DOI":"10.1001\/jamanetworkopen.2021.45653","article-title":"Birth outcomes of neonates exposed to marijuana in utero: a systematic review and meta-analysis","volume":"5","author":"Marchand","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.japh.2020.06.009","article-title":"CBD for the treatment of pain: what is the evidence?","volume":"60","author":"Svensson","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/d41586-019-02524-5","article-title":"The reality behind cannabidiol's medical hype","volume":"572","author":"Eisenstein","year":"2019","journal-title":"Nature"},{"key":"R5-20260826","first-page":"48","article-title":"Considerations and implications of cannabidiol use during pregnancy","volume":"24","author":"Sarrapfour","year":"2020","journal-title":"Curr Pain Headache Rep"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: a review","volume":"269","author":"Lowe","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1186\/s12889-022-14057-0","article-title":"Cannabidiol use and perceptions in France: a national survey","volume":"22","author":"Casanova","year":"2022","journal-title":"BMC Public Health"},{"key":"R9-20260826","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1503\/cmaj.211236","article-title":"Reasons for cannabis use during pregnancy and lactation: a qualitative study","volume":"193","author":"Vanstone","year":"2021","journal-title":"CMAJ"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:02:30Z","timestamp":1787742150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005603"}},"subtitle":["Findings From the International Cannabis Policy Study"],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005603","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"assertion":[{"value":"2024-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}